OLPX — Stock Film
STOCK FILMSCENE 1/11OLPX · $2.07
Stock Expert AI presents
OLPX
Olaplex Holdings, Inc
~5 min film100% real numbersplain English
WHAT DOES THIS COMPANY DO?
Olaplex Holdings, Inc. What it actually does.

Manufactures and sells hair care products. Offers shampoos and conditioners for hair treatment. Now — the numbers.

on the stock market since 2021
278 employees
$1.4B market value
Revenue last year:
$423M
The loss that same year:
$9.3M
Sales don’t cover the costs; the gap drains from the cash pile every year.

The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.

THE SALES TREND
Sales have been shrinking.

An average decline of 8% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.

$598.4M
2021
2022
2023
2024
$423M
2025
In the vault right now:
$318.7M
DEBT: $352.3M
At this pace, that money lasts about 34.4 years.

At this burn rate the cash pile isn’t the pressing question — for now, time is on the company’s side.

THE PRICE TAG
MARKET VALUE / ANNUAL SALES
3.3×

This company is not turning a profit, so the market is pricing its sales instead: 3.3× for every dollar of annual revenue.

Against companies in its own sector, it looks cheaper than 42% of them.

Analysts' average target sits 2% below today's price.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
42
weak

Clearly below the class average.

FINANCIAL STRENGTH
62
average

A solid grade overall — yet the debt outweighs the cash. The strength here comes from earnings power.

VALUATION
42
weak

Clearly below the class average.

GROWTH
12
very weak

Clearly below the class average.

PRICE MOMENTUM
78
strong

Clearly above the class average — a step short of the very top.

WORTH WATCHING

Growth: Sales growth trails the sector average.

Business Quality: Profit power and business quality trail similar companies in the sector.

THE FIVE-YEAR JOURNEY
A long and steep decline.

An investor who bought at the very peak is down 93% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

1
THE BRIGHT SIDE · 1/1
The product is selling

Sales run at $423.0M a year. A small number, but proof the product has real buyers.

1
THE RISKS · 1/2
Small scale, thin loss

A loss of $9.3M against $423.0M in annual sales.

2
THE RISKS · 2/2
Executives lean toward selling

Over the last 12 months, executives reported 31 sells against just 4 buys. Not an alarm bell by itself, but a number worth watching.

FINALE · THE GRADE
grade pending

We don’t have a report card for this stock yet — the data isn’t mature enough to grade. No grade is information too: it means the evidence is thin.

One-line summary: few numbers, an untested story. Keep watching.

What would you like to do next?
Open the stock page →

Not covered, because the filings we hold do not carry it: the revenue breakdown.

This was a film — not investment advice.
Data: FMP & company filings
Sep 11, 2026 · stockexpertai.com · Stock Film